MCM
HALO icon

Monument Capital Management’s Halozyme HALO Stock Holding History

Monument Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,468
Closed -$2.01M – 232
2025
Q3 		$2.01M Buy
+27,468
New +$1.82M 0.5% 74

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Monument Capital Management's HALO Position: Q4 2025 in Review

Monument Capital Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 27,468 shares — an estimated $2.01M sold.

Monument Capital Management first reported a position in HALO in Q3 2025 and held it in 1 quarter. The position peaked at $2.01M in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Monument Capital Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Monument Capital Management sold 27,468 Halozyme shares in Q4 2025, an estimated $2.01M.
  • Monument Capital Management first reported a position in Halozyme in Q3 2025 and held it in 1 quarter.
  • Monument Capital Management's Halozyme position peaked at $2.01M in Q3 2025.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Monument Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.